DOXYCYCLINE

Abstract
In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #doxycycline
Dr Sharon Rees @reesprescribe
Day 1: The Tetracycline drug class was derived from soil bacteria ‘actinomycetes’. Tetracycline represents an early example of a broad-spectrum and semi-synthetic antibiotic. Modification to oxytetracycline to increase potency, oral absorption and t½ led to #doxycycline, approved by the in FDA 1967.
Dr Sharon Rees @reesprescribe
Day 2: #doxycycline is active against multiple infections, Gram positive and negative organisms, anaerobes, mycoplasmas, intra-cell chlamydiae, rickettsiae, as well as protozoan parasites. Can be used (where suitable) as oral single agent for methicillin-resistant Staphylococcus aureus.
Dr Sharon Rees @reesprescribe
Day 3: Mode of action. Bacteria have transport systems that admit tetracyclines (TCs), but human cells mostly do not uptake. #doxycycline binds to bacterial ribosome, prevents tRNA binding mRNA, inhibits protein synthesis, cell functions and replication. Predominantly bacteriostatic.
Dr Sharon Rees @reesprescribe
Day 3 (cont): TCs have anti-inflammatory/anti-oxidant properties that may be helpful for inflammatory conditions such as rosacea and periodontitis (low dose). Mechanism possibly via reduced cytokine production, such as TNF-decreased, IL-6, 8 and alpha decreased matrix metalloproteinases so decreased tissue remodel/destruction. Also impaired enzyme production such as phospholipase, so there's decreased prostaglandin synthesis.
Register now to continue reading
Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to our clinical or professional articles
-
New content and clinical newsletter updates each month